✦ LIBER ✦

Rituximab shows activity in B-cell chronic lymphocytic leukaemia

Book ID: 120865334
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2001
Weight: 121 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200113080-00032

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rituximab in B-Cell chronic lymphocytic

Rituximab in B-Cell chronic lymphocytic leukemia

✍ Thomas S Lin; Margaret S Lucas; John C Byrd 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Hypercalcaemia in B cell chronic lymphoc

Hypercalcaemia in B cell chronic lymphocytic leukaemia

✍ Olivier Fain; Abdellatif El M'Selmi; Christine Dosquet; Didier Meseure; Francloi 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 271 KB

B Lymphocyte Function in B Cell Chronic

B Lymphocyte Function in B Cell Chronic Lymphocytic Leukaemia

✍ Jeffrey A. Wolos; Frederick R. Davey 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 560 KB

Rituximab makes a difference in chronic

Rituximab makes a difference in chronic lymphocytic leukaemia

📂 Article 📅 2008 🏛 Adis International Limited (now part of Wolters Kl ⚖ 120 KB

Karyotypic evolution in B-cell chronic l

Karyotypic evolution in B-cell chronic lymphocytic leukaemia

✍ David Oscier; Margaret Fitchett; Tony Herbert; Richard Lambert 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 357 KB

Sequential cytogenetic studies were performed on a minimum of two and a maximum of nine occasions (mean 3.6) on the peripheral blood leucocytes of 112 patients with B-CLL. On initial cytogenetic analysis, 58 had a normal karyotype and 64 had a clonal abnormality. Karyotypic evolution occurred in 18

Rituximab and 17-allylamino-17-demethoxy

Rituximab and 17-allylamino-17-demethoxygeldanamycin induce synergistic apoptosis in B-cell chronic lymphocytic leukaemia

✍ Amy J. Johnson; Amy J. Wagner; Carolyn M. Cheney; Lisa L. Smith; David M. Lucas; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB